[go: up one dir, main page]

TNSN97155A1 - Procedes et intermediaires pour la preparation de derives de chromanol substitues - Google Patents

Procedes et intermediaires pour la preparation de derives de chromanol substitues

Info

Publication number
TNSN97155A1
TNSN97155A1 TNTNSN97155A TNSN97155A TNSN97155A1 TN SN97155 A1 TNSN97155 A1 TN SN97155A1 TN TNSN97155 A TNTNSN97155 A TN TNSN97155A TN SN97155 A TNSN97155 A TN SN97155A TN SN97155 A1 TNSN97155 A1 TN SN97155A1
Authority
TN
Tunisia
Prior art keywords
preparation
processes
intermediates
chromanol derivatives
substituted chromanol
Prior art date
Application number
TNTNSN97155A
Other languages
English (en)
Inventor
D Piscopio Anthony
M Hawkins Joel
Caron Stephane
E Kelly Sarah
W Raggon Jeffrey
J Castaldi Michael
W Dugger Robert
G Ruggeri Sally
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of TNSN97155A1 publication Critical patent/TNSN97155A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C33/40—Halogenated unsaturated alcohols
    • C07C33/50—Halogenated unsaturated alcohols containing six-membered aromatic rings and other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/025—Boronic and borinic acid compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

L’INVENTION CONCERNE DES PROCEDES POUR LA PREPARATION DE COMPOSES DE FORMULE (X) : ET LEURS ENANTIOMERES, FORMULE DANS LAQUELLE LE GROUPEMENT ACIDE BENZOIQUE EST FIXE EN POSITION DE 6 OU 7 DU NOYAU CHROMANE ET R1, R2 ET R3 REPRESENTENT DIVERS RADICAUX. ELLE CONCERNE EN OUTRE DES INTERMEDIAIRES UTILES DANS LA PREPARATION DE CE COMPOSE. APPLICATION : UTILISATION D'UN TEL COMPOSE COMME ANTAGONISTE DE LTB4.
TNTNSN97155A 1996-09-16 1997-09-15 Procedes et intermediaires pour la preparation de derives de chromanol substitues TNSN97155A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2637296P 1996-09-16 1996-09-16

Publications (1)

Publication Number Publication Date
TNSN97155A1 true TNSN97155A1 (fr) 2005-03-15

Family

ID=21831429

Family Applications (1)

Application Number Title Priority Date Filing Date
TNTNSN97155A TNSN97155A1 (fr) 1996-09-16 1997-09-15 Procedes et intermediaires pour la preparation de derives de chromanol substitues

Country Status (39)

Country Link
US (4) US6096906A (fr)
EP (1) EP0925292B1 (fr)
JP (1) JP3117730B2 (fr)
KR (1) KR100339164B1 (fr)
CN (1) CN1108298C (fr)
AP (1) AP726A (fr)
AT (1) ATE249452T1 (fr)
AU (1) AU713701B2 (fr)
BG (1) BG63542B1 (fr)
BR (1) BR9711482A (fr)
CA (1) CA2265043C (fr)
CO (1) CO4600635A1 (fr)
DE (1) DE69724801T2 (fr)
DK (1) DK0925292T3 (fr)
DZ (1) DZ2308A1 (fr)
EA (1) EA002204B1 (fr)
ES (1) ES2206738T3 (fr)
GT (3) GT199700104A (fr)
HN (1) HN1997000127A (fr)
HR (1) HRP970497B1 (fr)
ID (1) ID19613A (fr)
IL (1) IL128732A0 (fr)
IS (1) IS4980A (fr)
MA (1) MA24319A1 (fr)
NO (1) NO991254L (fr)
NZ (1) NZ334214A (fr)
OA (1) OA10995A (fr)
PA (1) PA8437901A1 (fr)
PE (1) PE109798A1 (fr)
PL (1) PL332351A1 (fr)
PT (1) PT925292E (fr)
SK (1) SK31399A3 (fr)
TN (1) TNSN97155A1 (fr)
TR (1) TR199900592T2 (fr)
TW (1) TW449579B (fr)
UA (1) UA58520C2 (fr)
WO (1) WO1998011085A1 (fr)
YU (1) YU13299A (fr)
ZA (1) ZA978291B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6436987B1 (en) * 2000-06-08 2002-08-20 Pfizer Inc. Crystalline forms of (3S-trans)-2-[3,4-dihydro-4-hydroxy-3-(phenylmethyl)-2H-1-benzopyran-7-yl]-4-(trifluoromethyl)-benzoic acid
BR0206771A (pt) * 2001-01-30 2004-02-25 Pfizer Prod Inc Processos para a preparação de cidos cromanilbenzóicos
AU4239302A (en) * 2001-06-28 2003-01-02 Pfizer Products Inc. Benzoic acid substituted benzopyrans for the treatment of atherosclerosis
JP2010534240A (ja) * 2007-07-23 2010-11-04 ザ ボード オブ トラスティーズ オブ ザ ユニバーシティ オブ イリノイ ボロン酸の反応性の調節系
US8338601B2 (en) * 2008-09-26 2012-12-25 Board Of Trustees Of The University Of Illinois Slow release of organoboronic acids in cross-coupling reactions
US20110218319A1 (en) * 2009-09-02 2011-09-08 E. I. Du Pont De Nemours And Company Polyaramid films comprising fluorovinylether functionalized aromatic moieties
WO2011028791A2 (fr) * 2009-09-02 2011-03-10 E. I. Du Pont De Nemours And Company Polyaramide comprenant des fractions aromatiques à fonctionnalité fluorovinyléther
AU2010289572A1 (en) 2009-09-02 2012-03-15 E. I. Du Pont De Nemours And Company Fluoroether functionalized aromatic diesters and derivatives thereof
WO2011028778A2 (fr) * 2009-09-02 2011-03-10 E. I. Du Pont De Nemours And Company Polyesters comprenant des fractions aromatiques à fonctionnalité fluorovinyléther
TW201127822A (en) * 2009-09-02 2011-08-16 Du Pont Fluorinated 4-oxo-chroman-carboxylates
AU2010289576B2 (en) * 2009-09-02 2015-07-16 E. I. Du Pont De Nemours And Company Polyester films with improved oil repellency
US8557980B2 (en) * 2010-02-18 2013-10-15 The Board Of Trustees Of The University Of Illinois Methods for forming protected organoboronic acids
WO2016149126A1 (fr) 2015-03-13 2016-09-22 The Board Of Trustees Of The Leland Stanford Junior University Inhibition de ltb4 pour prévenir et traiter le lymphoedème humain
KR102807066B1 (ko) * 2019-09-30 2025-05-15 주식회사 엘지화학 아민계 화합물 제조방법
CN117384617B (zh) * 2023-12-13 2024-03-29 中国石油大学(华东) 一种耐盐型胍胶压裂液交联剂水溶液及其制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9119920D0 (en) * 1991-09-18 1991-10-30 Glaxo Group Ltd Chemical compounds
DK0623122T3 (da) * 1992-01-23 1997-04-21 Pfizer Benzopyran og beslægtede LTB4-antagonister
MX9300312A (es) * 1992-01-23 1993-07-31 Pfizer Antagonistas benzopiranicos y relacionado de ltb.
KR950704291A (ko) * 1992-10-21 1995-11-17 알렌 제이. 스피겔 거울상 이성질체 시스-3-(4,6-디하이드록시크로만-3-일메틸)벤조산(enantiomeric cis-3-(4,6-dihydroxychroman-3-ylmethyl)benzoic acids)
CZ100095A3 (en) * 1992-10-21 1995-11-15 Pfizer Sulfonamide derivatives of hydroxy substituted alicyclic or heterocyclic compounds with condensed benzene nucleus and pharmaceutical preparations based thereon
JP3012339B2 (ja) * 1994-10-13 2000-02-21 ファイザー・インコーポレーテッド ベンゾピランおよびベンゾ縮合化合物、それらの製造、並びにロイコトリエンｂ▲下４▼（ｌｔｂ▲下４▼）アンタゴニストとしてのそれらの用途
WO1996011920A1 (fr) * 1994-10-13 1996-04-25 Pfizer Inc. Composes de benzopyranne et composes benzo-fusionnes, leur preparation et leur utilisation comme antagonistes de leucotriene b4 (ltb4)
US5539128A (en) * 1994-11-30 1996-07-23 Pfizer Inc. Processes and intermediates for preparing cis(+)3-[4,6-dihydroxy chroman-3-ylmethyl]-4-methoxyaniline

Also Published As

Publication number Publication date
CA2265043C (fr) 2003-01-14
PE109798A1 (es) 1999-01-13
NO991254L (no) 1999-05-14
CO4600635A1 (es) 1998-05-08
ID19613A (id) 1998-07-23
CN1108298C (zh) 2003-05-14
GT199700104AA (es) 1999-03-28
HN1997000127A (es) 1997-12-20
EA199900204A1 (ru) 1999-08-26
AP9701083A0 (en) 1997-10-31
PA8437901A1 (es) 2000-05-24
GT199700104BA (es) 1999-03-28
US6444826B1 (en) 2002-09-03
CA2265043A1 (fr) 1998-03-19
BR9711482A (pt) 1999-08-24
TR199900592T2 (xx) 1999-06-21
EA002204B1 (ru) 2002-02-28
JP2000502726A (ja) 2000-03-07
AU3781497A (en) 1998-04-02
BG63542B1 (bg) 2002-04-30
US20020099227A1 (en) 2002-07-25
JP3117730B2 (ja) 2000-12-18
AU713701B2 (en) 1999-12-09
HRP970497A2 (en) 1998-08-31
SK31399A3 (en) 2000-05-16
YU13299A (sh) 2001-03-07
US6288242B1 (en) 2001-09-11
TW449579B (en) 2001-08-11
ES2206738T3 (es) 2004-05-16
DZ2308A1 (fr) 2002-12-28
ZA978291B (en) 1999-03-15
CN1230954A (zh) 1999-10-06
PT925292E (pt) 2004-01-30
AP726A (en) 1999-01-29
US6355825B1 (en) 2002-03-12
OA10995A (en) 2001-11-06
IS4980A (is) 1999-02-16
BG103231A (en) 1999-12-30
DK0925292T3 (da) 2004-01-12
MA24319A1 (fr) 1998-04-01
EP0925292A1 (fr) 1999-06-30
DE69724801T2 (de) 2004-06-17
IL128732A0 (en) 2000-01-31
WO1998011085A1 (fr) 1998-03-19
KR100339164B1 (ko) 2002-06-01
GT199700104A (es) 1999-03-02
UA58520C2 (uk) 2003-08-15
US6096906A (en) 2000-08-01
HRP970497B1 (en) 2002-06-30
NZ334214A (en) 2000-09-29
DE69724801D1 (de) 2003-10-16
PL332351A1 (en) 1999-09-13
NO991254D0 (no) 1999-03-15
US20020042526A1 (en) 2002-04-11
EP0925292B1 (fr) 2003-09-10
ATE249452T1 (de) 2003-09-15
KR20000036136A (ko) 2000-06-26

Similar Documents

Publication Publication Date Title
TNSN97155A1 (fr) Procedes et intermediaires pour la preparation de derives de chromanol substitues
ATE254612T1 (de) Zuckerderivate, geliermittel, geliermittelzubereitungen, verfahren zu ihrer herstellung und gelzubereitungen
TNSN97190A1 (fr) Derives d'amines bicycliques.
EP1229094A3 (fr) Composition de polissage et procédé de polissage utilisant cette composition
DZ2495A1 (fr) Formule nouvelle de l'oméprazole-s.
IL158459A0 (en) Quinoline derivatives and quinazoline derivatives having azolyl group
DE69420421D1 (de) Zwischenprodukte für die Herstellung einer substituierten 2,5-Diamino-3-hydroxyhexan.
DK0810208T3 (da) N-substituerede hydroxyethylamino sulfaminsyrederivater til anvendelse som inhibitorer af retrovirale proteaser
DE60123933D1 (de) Fluoreszierende proben zur quantitativen bestimmung von zink
ATE209034T1 (de) Taxolderivate
FI903939A0 (fi) Benzopyranfoereningar, foerfaranden foer deras framstaellning och farmaceutiska kompositioner.
IE811312L (en) Benzopyran derivatives
IE830807L (en) Phenoxyalkylcarboxylic acid derivatives
ATE279411T1 (de) Fluorszierende marker
DK1095015T3 (da) Sulfonylamino-carboxylsyre-N-arylamider som aktivatorer for guanylatcyclase
ATE325788T1 (de) Kristalle von vitamin d derivaten und verfahren zu ihrer herstellung
EP1094055A4 (fr) Nouveaux derives vinylbenzene
BG102506A (bg) Фунгициден състав, съдържащ 2-имидазолин-5-он
MA27501A1 (fr) Derives d'imidazoquinoline en tant que ligands recepteurs de l'adenosine a3
ATE437865T1 (de) Flavanoide derivate als chemotherapeutika, chemopreventiva bzw. antiangiogenetische wirkstoffe
NZ237102A (en) Nitric acid esters of cyclohexanol derivatives, pharmaceutical compositions thereof and cyclohexanol derivatives as intermediates therefor
HU9301388D0 (en) Method for producing hydroxy-ethylene-isoster type compounds of hiv-protease inhibiting effect containing dithiolamine-glycine
ATE298320T1 (de) Kontrastmittel
FR2703880B1 (fr) Utilisation de dérivés de l'acide 7-éthynyl alpha-(méthoxy-méthylène) 1-naphtalène acétique pour la préparation de compositions fongicides.
DE69019423D1 (de) Epoxybernsteinsäurederivate, verwendbar als spezifische Hemmer von Cathepsin B.